Vitamin D decreases CD40L gene expression in ulcerative colitis patients: A randomized, double-blinded, placebocontrolled trial

Sharifi, Amrollah and Honarvar, Mohammad Reza and Amiriani, Taghi and Yousefi Rad, Esmaeil (2019) Vitamin D decreases CD40L gene expression in ulcerative colitis patients: A randomized, double-blinded, placebocontrolled trial. GASTROINTESTINAL TRACT.

Preview

Text tjg-31-2-99.pdf Download (208kB) | Preview

Abstract

ABSTRACT Background/Aims: The interaction of CD40 ligand (CD40L) and CD40 triggers the induction of pro-inflammatory cytokines. It has been proposed that vitamin D deficiency might be an important factor, which causes or aggregates the autoimmune situations. The aim of the present study was to assess the effect of vitamin D on CD40L gene expression in patients with ulcerative colitis (UC). Materials and Methods: Ninety mild-to-moderate UC patients were randomized to receive a single injection of 7.5 mg cholecalciferol or 1 mL normal saline. At baseline and 90 days following the intervention, RNA samples from whole blood were obtained. Fold changes in CD40L mRNA expression were determined for each patient using the 2-ΔΔCq method. The data were analyzed. Results: The serum levels of vitamin D and calcium increased only in the vitamin D group (p<0.05). Relative to baseline values, the CD40L gene expression fold change was significantly lower in the vitamin D group compared with the placebo group (median±interquartile range: 0.34±0.30 vs 0.43±1.20, respectively, p=0.016). Conclusion: The results of this study showed that vitamin D administration in mild-to-moderate UC patients led to the downregulation of the CD40L gene, which is an essential part of inflammatory pathways. Keywords: Cholecalciferol, Inflammatory bowel disease, ulcerative colitis, CD40 ligand

Actions (login required)

View Item